OrbiMed’s Spark Therapeutics, Inc. Common Stock ONCE Stock Holding History

OrbiMed’s Portfolio ONCE Stock Details ONCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-244,900	Closed	-$23.8M	–	154
2019 Q3	$23.8M	Buy	244,900 +25,000	+11%	+$2.5M	0.45%	53
2019 Q2	$22.5M	Buy	+219,900	New	+$23.7M	0.35%	65
2017 Q4	–	Sell	-430,016	Closed	-$38.3M	–	152
2017 Q3	$38.3M	Buy	+430,016	New	+$32.7M	0.37%	71
2015 Q3	–	Sell	-166,500	Closed	-$10M	–	144
2015 Q2	$10M	Buy	166,500 +39,500	+31%	+$2.61M	0.08%	105
2015 Q1	$9.84M	Buy	+127,000	New	+$7.31M	0.08%	105

OrbiMed's ONCE Position: Q4 2019 in Review

OrbiMed sold out of Spark Therapeutics, Inc. Common Stock (ONCE) in Q4 2019, closing a stake of 244,900 shares — an estimated $23.8M sold.

OrbiMed first reported a position in ONCE in Q1 2015 and held it in 5 quarters. The position peaked at $38.3M in Q3 2017. 0 funds tracked by Wall St. Rank hold ONCE as of Q4 2019.

OrbiMed reported no remaining Spark Therapeutics, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
OrbiMed sold 244,900 Spark Therapeutics, Inc. Common Stock shares in Q4 2019, an estimated $23.8M.
OrbiMed first reported a position in Spark Therapeutics, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
OrbiMed's Spark Therapeutics, Inc. Common Stock position peaked at $38.3M in Q3 2017.
0 funds tracked by Wall St. Rank held Spark Therapeutics, Inc. Common Stock as of Q4 2019.

Based on OrbiMed's 13F filing for Q4 2019, filed 14 Feb 2020.